World Investment Week is a carefully organized and promoted global event by the International Organization of Securities Commissions (IOSCO), aimed at strengthening the critical area of investor education and protection. In today's globalized economic system, financial markets of various countries are intertwined, and investment activities are becoming increasingly complex. In this context, the 2024 World Investment Week focuses on cutting-edge and critical investment themes, providing investors with a window of insight into the market....

Five years ago, the China Securities Regulatory Commission will5the moon15The day is designated as the "National Investor Protection Promotion Day" to further promote a rational investment culture, strengthen investor protection awareness, and comprehensively build a new pattern of investor protection in the capital market. Various forms of investor protection activities are actively organized and mobilized across the country to deepen the concept of investor protection.2024year5the moon15The day is the sixth edition“5·15National Investor Protection Promotion Day”This year's theme is“Caring for investors, working together to take action——Promote high-quality development and boost investor confidence”....

The Anti Monopoly Law and the Anti Unfair Competition Law both regulate competitive behavior or relationships, and belong to the category of competition law.

Investors are the foundation of the development of the capital market. Respecting, revering, and protecting investors is a concrete manifestation of the capital market's practice of people-centered development. Protecting investors and safeguarding the vital interests of the people in the jurisdiction is the foundation for the sustained and healthy development of the capital market. Improving the quality of listed companies, promoting the formation of an equity culture that serves and rewards investors, strengthening the primary responsibility of securities, fund, and futures operating institutions to protect investors, fulfilling their duties to provide good investor services, diligently promoting the popularization and education of securities and futures knowledge, and safeguarding the legitimate rights and interests of investors are our fundamental mission and unshirkable obligati...

In recent years, the pharmaceutical industry has been calling for a reduction in taxes and fees. After the implementation of policies such as replacing business tax with value-added tax and the two invoice system, pharmaceutical companies have felt more direct financial and tax pressure. On March 4, Zhao Yixin, a deputy to the National People's Congress and chairman of Shandong Xinhua Medical Devices Co., Ltd., proposed at the "two sessions" of the medical sector representatives' forum that at this stage, the enterprise value-added tax rate is high, the enterprise business burden is heavy, and in the face of opportunities and challenges, the government needs more encouragement and support. Public information shows that there is currently a lack of financial and tax incentives for pharmaceutical R&D investment. Although the government has incentive policies for addi...